This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABT-510

AbbVie Inc.

Drug Names(s): ABT-510

Description: ABT-510 is an anti-angiogenic, thrombospondin-1 (TSP-1) mimetic peptide. ABT-510, like TSP-1, causes endothelial cell apoptosis via activation of Fas/Fas ligand (FasL) and the Src-related kinase p59 Fyn pathway ultimately leading to cell death.


ABT-510 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug